For citations:
Goryacheva N.A., Rzhevskiy D.I., Slashheva G.A., Novikova N.I., Kisilevskiy M.V., Chikileva I.O., Vlasenko R.Ya., Dyachenko I.A., Murashev A.N., Bondarenko D.A. Preclinical acute toxicity studies of the CAR technology products for malignant neoplasms therapy on the example of the «anti-HER2-CAR-T/CAR-NK». Toxicological Review. 2022;30(6):377-385. (In Russ.) https://doi.org/10.47470/0869-7922-2022-30-6-377-385
Email this article 